Trial intelligence / Profile preview

Low-dose ketamine as adjuvant to morphine in neuropathic cancer pain

2012-001175-36Phase 4Terminated

Sponsor
Haukeland University Hospital
Start
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketamine in Neuralgia, sponsored by Haukeland University Hospital. Started Jun 2012; status: terminated.

02

Drugs

ketamine
03

Conditions

Neuralgia

Beyond the preview

Go deeper on 2012-001175-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001175-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call